Axel Schörling
Chief Executive Officer chez EQL PHARMA AB
Fortune : 1 M $ au 31/03/2024
Profil
Axel Schörling is currently the President & Chief Executive Officer at EQL Pharma AB since 2022 and the Director at Gasporox AB since 2023.
Previously, he worked as the Director-Business Controlling at Perstorp AB.
Mr. Schörling holds a graduate degree from Chalmers University of Technology and Handelshögskolan i Göteborg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQL PHARMA AB
0,88% | 31/03/2023 | 257 113 ( 0,88% ) | 1 M $ | 31/03/2024 |
Postes actifs de Axel Schörling
| Sociétés | Poste | Début |
|---|---|---|
| EQL PHARMA AB | Chief Executive Officer | 17/08/2022 |
| GASPOROX AB | Director/Board Member | 01/01/2023 |
Anciens postes connus de Axel Schörling
| Sociétés | Poste | Fin |
|---|---|---|
| PERSTORP HOLDING AB (PUBL.) | Corporate Officer/Principal | - |
Formation de Axel Schörling
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GASPOROX AB | Commercial Services |
| EQL PHARMA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Perstorp AB
 Perstorp AB Chemicals: SpecialtyProcess Industries Perstorp AB manufactures and supplies specialty chemicals. The company was founded in 1881 and is headquartered in Perstorp, Sweden. | Process Industries |
